Kineret, Anakinra News

A new study shows that Kineret , a medication approved for the treatment of rheumatoid arthritis , is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease .

A new study shows that Kineret , a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease .

Biologic Response Modifiers stimulate or restore the ability of the immune system to fight disease or infection.

Main Category: Arthritis / Rheumatology Also Included In: Regulatory Affairs / Drug Approvals Article Date: 03 Aug 2011 - 7:00 PDT opinions Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration has approved a subcutaneous formulation of ORENCIA for the treatment of adults with moderate to severe rheumatoid ...

A Bristol-Myers Squibb Company has announced that the FDA has approved a subcutaneous formulation of ORENCIA for the treatment of adults with moderate to severe rheumatoid arthritis .

The effectiveness of biologic medications, like all other medications, is dependent on patients' adherence, a challenging proposition.